As of the close on May 7, 2024, Antibe Therapeutics Inc.'s stock has declined approximately 46.36% over the past 52 weeks. The 50-day moving average sits at 0.63, while the 200-day moving average is 0.65.
| 52-Week Price Change | -46.36% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 0.65 |
Antibe Therapeutics Inc.'s most recent stock split took place on December 1, 2020 with a 10:1 split ratio.
| Last Split Date | 12/1/2020 |
| Split Ratio | 10:1 |
Already premium?